Osteoporosis is a major health problem characterized by compromised bone strength.
Osteoporosis is a major health problem characterized by compromised bone strength. [1] The number of people with osteoporosis increases as the population ages. Increasing number of osteoporotic fractures may have a negative impact on economics and quality of life of patients. [2] Bisphosphonates are synthetic analogues of pyrophosphate and have been used effectively in the treatment of osteoporosis with considerable clinical benefit in reduction of bone fragility for many years. They impair bone resorption by inhibition of osteoclast function and reducing osteoclast number. This gives rise to bone turnover diminution and bone mineral density (BMD) improvement resulting in fracture risk reduction. [3] Bisphosphonates are known to be safe and effective agents in short-term usage. Osteoblast function decreases due to inhibition of osteoclast function and impair bone turnover for prolonged periods. Over-suppression of bone turnover results with impairment of remodelization ability of bone with long-term exposure to bisphosphonates. This 
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ABSTRACT
A 67-year-old female patient admitted to our outpatient clinic suffering from pain in both thighs for one year without any history of trauma. Patient was receiving alendronate therapy for five years. Physical examination revealed pain increasing with weight-bearing in both thighs with full range of hip and knee movements. Radiographs showed an area of thickened cortex of middle femoral diaphysis in both femurs, but no fracture. Bone scan showed a single area of increased uptake of radioisotope. These images were compatible with stress fractures of both femurs. Dual-energy X-ray absorptiometry revealed a T-score of -3.2 for the lumbar spine and -3.5 for the hip. Alendronate treatment was ceased. Calcium and vitamin D treatment were started. Patient was performed prophylactic surgical stabilization by titanium elastic nails in May 2009. On first day after the surgery, unsupported mobilization and weight-bearing activities were started. Upon persistence of pain on left thigh, plate fixation was performed for the nonunion in June 2012. Patient is now pain-free and able to walk with full weight-bearing without any complications.
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causes accumulation of low energy micro damage, resulting in bone fragility, which could normally be repaired in healthy bone tissue. [4, 5] A number of case studies have shown increased bone fragility with prolonged bisphosphonate therapy. [6] [7] [8] [9] In this article, we report a patient who received longterm bisphosphonate therapy and presented with bilateral femur diaphysis stress fractures. Our article emphasizes the importance of taking possible stress fractures into consideration in patients with long-term bisphosphonate therapy, who present with vague thigh pain.
CASE REPORT
A 67-year-old female patient presented to the department of orthopaedics suffering from pain in both thighs for one year without any history of trauma. Her medical history included diabetes mellitus, diaphragmatic hernia, gastroesophageal reflux, hypothyroidism, menopause at the age of 49, and osteoporosis. Five years ago, the reason of the pain was initially thought to be osteoporosis. She was administered oral alendronate treatment ever since. A written informed consent was obtained from the patient. Physical examination revealed pain in both thighs increasing with weight-bearing activity. Body mass index was 28 kg/m 2 . Thyroid function tests were normal. Biochemical markers of bone turnover were normal. The patient's diabetes mellitus was controlled with oral antidiabetic drugs. Radiographic examination showed an area of thickened cortices of middle femoral diaphysis on both extremities but no evidence of fracture ( Figure 1 ). Bone scanning with technetium99m showed a single area of increased uptake of radioisotope in the middle third of the diaphysis of both femurs corresponding to the site of cortical thickening (Figure 2 ). These images were compatible with microfractures (stress fracture) of both femurs. Dual-energy X-ray absorptiometry revealed T score of -3.2 for lumbar spine and -3.5 for hip. Despite the bisphosphonate treatment, no improvement in BMD was seen compared to previous evaluations. We thought that stress fractures may be associated with long-term usage of bisphosphonates and we discontinued alendronate treatment. Femoral stress fractures were treated by titanium elastic nails in May 2009 (Figure 3) . However, upon persistence of pain on left thigh, plate fixation was performed for nonunion in June 2012 (Figure 4 ). Both femoral stress 
DISCUSSION
Bisphosphonates have been used as a first line treatment modality for osteoporosis and reduction of related fracture risks. With prolonged bisphosphonates usage, impairment of bone remodeling increases. This causes accumulation of micro damage and susceptibility to fractures which are usually short oblique or transverse. [8] [9] [10] These fractures radiologically demonstrate thickening of the lateral cortical margin of bone which is described as "beaking" as in our patient. [9] The effects of alendronate take effect for at least five years after discontinuation of the drug. [11] Some authors recommend stopping alendronate intake after five years in most patients. [5] Additional studies are needed to determine how long bisphosphonates can be used safely. Cortical thickening has a higher risk of progressing to complete stress fractures. [10] Insufficiency fracture is a type of stress fracture and has three characteristic fracture patterns consisting of cortical thickening, transverse fracture, and medial cortical spike in subtrochanteric and femoral shaft regions. [9] The fracture lines of our patient were short oblique with lateral cortical thickening. Although the bulky muscles of the thigh prevented the proper palpation of the femur, it could be detected in early stage. However, the sensitivity of plain radiographs in the early stages may be as low as 10%, rising to between 30% and 70% at follow-up. [12] [13] [14] [15] The majority of patients often describe a prodromal pain in thigh for several weeks or even months before the occurrence of the fracture. Importantly, at the investigation process, if stress fractures are detected prior to displacement, prophylactic fixation should be considered. It is unclear whether bisphosphonate therapy should be stopped or not. The preferred implant reported in the literature for the fixation of these fractures is rigid intramedullary nails with locking screws. Long cephalomedullary nails are now being considered for fixation, particularly to treat the subtrochanteric fractures. For our patient, we stopped bisphosphonate therapy and performed elastic nails to stimulate healing by micro-movement at the fracture line while not triggering stress rising point at the end of the nail.
Close monitoring of patients on long-term bisphosphonates is necessary. [16, 17] Recently, Odvina et al. [10] reported nine patients who sustained atypical spontaneous fractures while on alendronate therapy for three to eight years. Six of the nine patients had delayed or absent fracture healing for four months to two years during alendronate therapy, and four showed delayed fracture healing for eight to 12 months even after discontinuation of alendronate. The nonunion of the left femoral shaft fracture of our patient might be due to the lasting effects of the longterm bisphosphonate therapy after cessation while the right femoral shaft fracture healed at third month. Visekruna et al. [18] reported on three patients with atypical subtrochanteric stress fractures who were on long-term alendronate, and one of them had no radiographic proof of union at 22 months. Many other reports described patients who experienced femoral stress fractures while on bisphosphonate therapy and delayed union or nonunion of the femoral shaft fracture despite discontinuation of bisphosphonates. It is thought that suppression of bone turnover caused by long-term usage of bisphosphonates is related to bone healing problems. Of atypical femoral fractures, 26% were reported to be delayed union. [19] Our patient's symptoms for right thigh ended at the third month after the surgery. However, the patient was still suffering from the pain of her left thigh. The persisting left thigh pain was not affecting her daily life. Thus, we decided to follow-up the patient until the union. Unfortunately, at the end of the third year, the pain was still persisting, and there was no evident union. Then, patient underwent osteosynthesis surgery and was free of pain of her left and right thighs after five months.
In conclusion, although previous studies have shown the efficacy of bisphosphonates in the first five years of therapy, additional studies are needed to determine how long bisphosphonates can be given safely. We recommend discontinuing alendronate after five years. Patients who have been on long-term bisphosphonates should be evaluated in terms of fracture. When stress fracture is detected, prophylactic fixation should be considered to prevent progression to complete fracture and the fracture should be monitored closely for healing.
